Delivery Order SPE2DR25D3103-SPE2DR26F9F43
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,365.40 to AmerisourceBergen Drug Corp for Fentanyl 100 mcg/2 mL vials on July 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,978.16 to AmerisourceBergen Drug Corp for Fentanyl 100 mcg/2 mL vials on October 23, 2025, with an ultimate completion date of October 24, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. Performance of this delivery order will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Fentanyl 250 mcg/5 mL vials with a ceiling value of $2,692.10. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-competitive, competitively awarded delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.68 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 micrograms per 2 milliliter vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,162.00 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Fentanyl 2,500 micrograms per 50 milliliter vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Fentanyl 100 mcg/2 mL vials with a ceiling value of $2,448.68. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement for federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl 250 MCG/5 ML vials on November 10, 2025, with an ultimate completion date of November 12, 2025. The contract, valued at $1,569.31, was awarded on a firm fixed-price basis without any set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,889.68 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 4565795691 - FENTANYL 250 MCG/5 ML VIAL 5ML, a critical pharmaceutical product, with a completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the...
- The Defense Logistics Agency awarded a delivery order valued at $1,017.34 to AmerisourceBergen Drug Corp for the supply of Fentanyl 1,000 micrograms per 20 milliliter vials on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order was not set-aside and represents a competitive award issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- This delivery order awards AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, a contract valued at $1,658.68 for the supply of Fentanyl 100 micrograms/2 milliliters. The contract represents a firm fixed-price delivery order under a non-competitive set-aside, awarded by the Medical Supply Chain division of the Defense Logistics Agency on July 14, 2025, with an ultimate completion date of August 8, 2025. The place of performance is located in...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F43Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Fentanyl 50 mcg/mL vials with a ceiling value of $1,220.24. The contract, awarded on November 13, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and utilizes no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive portfolio of federal medical contracts demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/13/25 |